China should provide medical care, compensation to HIV-positive blood donors, Piot says

UNAIDS Executive Director Peter Piot on Thursday encouraged the Chinese government to provide compensation and medical care to thousands of people who contracted HIV through the government-supported blood transfusions in the late 1990s and early 2000s, AFP/AsiaOne News reports.

According to AFP/AsiaOne News, many of the 40,000 HIV-positive people living in China's Henan province were infected with the virus through unsanitary blood collection drives approved by the local government.

Piot said he will raise the issue during a meeting with Vice Premier Li Keqiang on Friday. Piot called the situation "incredibly tragic," adding that Chinese courts have not yet resolved the issue of compensation for the affected people.

Although the government has created guidelines to provide HIV-positive people in Henan with the latest antiretroviral drugs, patients are "still dying" because they do not have access to the medication, Piot said. According to UNAIDS, about 700,000 people in China are living with HIV/AIDS and an estimated 50,000 new HIV cases occurred in 2007 (AFP/AsiaOne News, 9/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug